Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,276,776 papers from all fields of science
Search
Sign In
Create Free Account
tretinoin microsphere
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Tretinoin
Tretinoin 0.001 MG/MG Topical Gel
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Adapalene
William John Waugh
,
S. Noble
,
L. Scott
Drugs
2012
Corpus ID: 195688122
SummaryAbstractAdapalene (Differin®) is a retinoid agent indicated for the topical treatment of acne vulgaris. In clinical trials…
Expand
2010
2010
Study of the Efficacy and Tolerability of 0.04% Tretinoin Microsphere Gel for Preadolescent Acne
L. Eichenfield
,
C. Matiz
,
A. Funk
,
S. Dill
Pediatrics
2010
Corpus ID: 12550847
OBJECTIVES: The goals were to assess the degree of improvement of facial acne after treatment with the 0.04% tretinoin…
Expand
2008
2008
Photographic assessment of tretinoin microsphere gel in moderate acne.
S. Feldman
,
M. Nighland
Journal of Drugs in Dermatology
2008
Corpus ID: 28823943
BACKGROUND True objective measures for assessing responsiveness to acne treatments are lacking. Photographic documentation can…
Expand
2007
2007
Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe…
L. Kircik
Cutis (New York, N.Y.)
2007
Corpus ID: 24335542
Acne is characterized by different types of lesions at different stages of development. Therefore, combination therapy may offer…
Expand
2005
2005
Cumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%.
J. Dosik
,
Kenneth E. Homer
,
S. Arsonnaud
Cutis (New York, N.Y.)
2005
Corpus ID: 21244616
Despite the many beneficial effects of dermatologic applications, most of the current treatments for acne cause local irritation…
Expand
Review
2004
Review
2004
Spotlight on Adapalene in Acne Vulgaris
William John Waugh
,
S. Noble
,
L. Scott
American Journal of Clinical Dermatology
2004
Corpus ID: 35537153
Adapalene (Differin®) is a retinoid agent indicated for the topical treatment of acne vulgaris. In clinical trials, 0.1…
Expand
2003
2003
Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations.
A. Greenspan
,
C. Loesche
,
+5 authors
P. Soto
Cutis (New York, N.Y.)
2003
Corpus ID: 11415036
Forty-two subjects with normal skin were enrolled in a single-center study to assess the cumulative irritancy potential of…
Expand
2003
2003
Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents.
Barbara Brand
,
R. Gilbert
,
+4 authors
Andrew-Marc Soloff
Journal of American Academy of Dermatology
2003
Corpus ID: 33864986
This randomized, investigator-blinded study evaluated the level of skin tolerance to adapalene gel 0.1%, tretinoin cream 0.025…
Expand
2001
2001
Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
Diane Thiboutot
,
Gold Mh
,
+6 authors
Maria J. Baker
Cutis (New York, N.Y.)
2001
Corpus ID: 40001454
A prior meta-analysis of 5 randomized controlled trials indicates that adapalene gel 0.1% is as effective as tretinoin gel 0.025…
Expand
2001
2001
Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
N. Egan
,
M. Loesche
,
M. Baker
Cutis (New York, N.Y.)
2001
Corpus ID: 37551168
Poor patient compliance is one of the main reasons for treatment failure in acne. Our objective was to evaluate the tolerability…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required